CORTICOSTEROID NOS for Crohn's disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where CORTICOSTEROID NOS was used for Crohn's disease.
Most Reported Side Effects for CORTICOSTEROID NOS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 89 | 11.8% | 20 | 26 |
| Drug ineffective | 80 | 10.6% | 11 | 29 |
| Drug ineffective for unapproved indication | 46 | 6.1% | 15 | 4 |
| Pyrexia | 42 | 5.6% | 13 | 33 |
| Product use in unapproved indication | 29 | 3.8% | 8 | 13 |
| Pain | 26 | 3.4% | 0 | 10 |
| Diarrhoea | 25 | 3.3% | 5 | 12 |
| Fatigue | 25 | 3.3% | 5 | 11 |
| Condition aggravated | 24 | 3.2% | 7 | 13 |
| Sepsis | 24 | 3.2% | 10 | 13 |
| Cytomegalovirus infection | 22 | 2.9% | 1 | 10 |
| Blood glucose increased | 21 | 2.8% | 0 | 5 |
| Respiratory failure | 21 | 2.8% | 8 | 19 |
| Rash | 19 | 2.5% | 2 | 12 |
| Arthralgia | 18 | 2.4% | 2 | 9 |
Other Indications for CORTICOSTEROID NOS
Product used for unknown indication (143)
Immunosuppression (33)
Immunosuppressant drug therapy (26)
Rheumatoid arthritis (22)
Acute lymphocytic leukaemia (17)
Asthma (15)
Prophylaxis against transplant rejection (15)
Eczema (10)
Renal transplant (10)
Acute graft versus host disease (9)
Other Drugs Used for Crohn's disease
ADALIMUMAB (99,540)
INFLIXIMAB (40,796)
VEDOLIZUMAB (28,718)
USTEKINUMAB (22,537)
RISANKIZUMAB-RZAA (12,561)
INFLIXIMAB-DYYB (10,657)
HUMIRA (10,174)
CERTOLIZUMAB PEGOL (8,758)
UPADACITINIB (4,390)
MESALAMINE (2,930)